Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $33.0250 (5.34%) ($33.0250 - $33.0250) on Mon. Apr. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.89% (three month average) | RSI | 53 | Latest Price | $33.0250(5.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 1.5% a day on average for past five trading days. | Weekly Trend | IOVA advances 1.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(46%) XBI(42%) ARKG(40%) IWO(39%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.945% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.945% (StdDev 3.89%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $31.33(5.41%) | 10 Day Moving Average | $30.86(7.02%) | 20 Day Moving Average | $30.87(6.98%) | To recent high | -37.2% | To recent low | 15.2% | Market Cap | $4.836b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |